The use of magnetic resonance imaging in the imaging of selected heart diseases - a review of the current literature
DOI:
https://doi.org/10.12775/JEHS.2023.14.01.016Keywords
cardiovascular diseases, magnetic resonance imaging, MRI, diagnosticAbstract
Cardiovascular diseases are still the most common cause of death worldwide [1]. Magnetic resonance imaging (MRI) is an advanced diagnostic technique that has become widely used in many fields of medicine, including the diagnosis of heart disease. MRI offers a non-invasive and safe approach to the anatomical and functional assessment of the heart, which enables characterization of the structure and function of this important organ [2]. In this text, we present the current state of knowledge on magnetic resonance imaging in selected heart diseases.
References
Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, Grandner MA, Lavretsky H, Perak AM, Sharma G, et al; on behalf of the American Heart Association. Life’s Essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association.Circulation. 2022; 146:e18–e43. doi: 10.1161/CIR.0000000000001078
Liu TT. MRI in systems medicine. Wiley Interdiscip Rev Syst Biol Med. 2020 Jan;12(1):e1463. doi: 10.1002/wsbm.1463. Epub 2019 Jul 31. PMID: 31365953.
Dusenbery SM, Jerosch-Herold M, Rickers C, et al. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. J Am Coll Cardiol. 2014;63(17):1778–85
Fogel MA, Anwar S, Broberg C, Browne L, Chung T, Johnson T, Muthurangu V, Taylor M, Valsangiacomo-Buechel E, Wilhelm C. Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association. Circ Cardiovasc Imaging. 2022 Jun;15(6):e014415. doi: 10.1161/CIRCIMAGING.122.014415. Epub 2022 Jun 21. PMID: 35727874; PMCID: PMC9213089
Nussbaumer C, Bouchardy J, Blanche C, Piccini D, Pavon AG, Monney P, Stuber M, Schwitter J, Rutz T. 2D cine vs. 3D self-navigated free-breathing high-resolution whole heart cardiovascular magnetic resonance for aortic root measurements in congenital heart disease. J Cardiovasc Magn Reson. 2021 May 27;23(1):65. doi: 10.1186/s12968-021-00744-1. PMID: 34039356; PMCID: PMC8157643.
Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 Apr 2;73(12):e81-e192. doi: 10.1016/j.jacc.2018.08.1029. Epub 2018 Aug 16. Erratum in: J Am Coll Cardiol. 2019 May 14;73(18):2361-2362. PMID: 30121239.
Nguyen KL, Hu P, Finn JP. Cardiac Magnetic Resonance Quantification of Structure-Function Relationships in Heart Failure. Heart Fail Clin. 2021 Jan;17(1):9-24. doi: 10.1016/j.hfc.2020.08.001. Epub 2020 Oct 28. PMID: 33220890; PMCID: PMC8171432.
Jahnke C, Spampinato RA, Oebel S, Lindemann F, Bollmann A, Hindricks G, Paetsch I. Cardiovascular magnetic resonance pulmonary perfusion for functional assessment of pulmonary vein stenosis. Int J Cardiol. 2023 Apr 1;376:147-153. doi: 10.1016/j.ijcard.2023.02.011. Epub 2023 Feb 13. PMID: 36791965.
Shah TR, Beig JR, Choh NA, Rather FA, Yaqoob I, Jan VM. Phase contrast cardiac magnetic resonance imaging versus transoesophageal echocardiography for the evaluation of feasibility for transcatheter closure of atrial septal defects. Egypt Heart J. 2022 Apr 13;74(1):27. doi: 10.1186/s43044-022-00269-7. PMID: 35416569; PMCID: PMC9008100.
Bhatla P, Tretter JT, Ludomirsky A, Argilla M, Latson LA Jr, Chakravarti S, Barker PC, Yoo SJ, McElhinney DB, Wake N, Mosca RS. Utility and Scope of Rapid Prototyping in Patients with Complex Muscular Ventricular Septal Defects or Double-Outlet Right Ventricle: Does it Alter Management Decisions? Pediatr Cardiol. 2017 Jan;38(1):103-114. doi: 10.1007/s00246-016-1489-1. Epub 2016 Nov 11. PMID: 27837304.
Vermes E, Iacuzio L, Levy F, Bohbot Y, Renard C, Gerber B, Maréchaux S, Tribouilloy C. Role of Cardiovascular Magnetic Resonance in Native Valvular Regurgitation: A Comprehensive Review of Protocols, Grading of Severity, and Prediction of Valve Surgery. Front Cardiovasc Med. 2022 Jul 7;9:881141. doi: 10.3389/fcvm.2022.881141. PMID: 35872899; PMCID: PMC9300884.
Buchner S, Debl K, Schmid FX, Luchner A, Djavidani B. Cardiovascular magnetic resonance assessment of the aortic valve stenosis: an in vivo and ex vivo study. BMC Med Imaging. 2015 Aug 26;15:34. doi: 10.1186/s12880-015-0076-x. PMID: 26306577; PMCID: PMC4548454.
Qureshi MY, O'Leary PW, Connolly HM. Cardiac imaging in Ebstein anomaly. Trends Cardiovasc Med. 2018 Aug;28(6):403-409. doi: 10.1016/j.tcm.2018.01.002. Epub 2018 Jan 12. PMID: 29409687.
Bhatt DL, Lopes RD, Harrington RA. Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA. 2022 Feb 15;327(7):662-675. doi: 10.1001/jama.2022.0358. Erratum in: JAMA. 2022 May 3;327(17):1710. PMID: 35166796.
Bulluck H, Dharmakumar R, Arai AE, Berry C, Hausenloy DJ. Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions. Circulation. 2018 May 1;137(18):1949-1964. doi: 10.1161/CIRCULATIONAHA.117.030693. PMID: 29712696; PMCID: PMC5933067.
Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H, Hood S, Owens C, Watkins S, Layland J, Lindsay M, Peat E, Rae A, Behan M, Sood A, Hillis WS, Mordi I, Mahrous A, Ahmed N, Wilson R, Lasalle L, Généreux P, Ford I, Berry C. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol. 2014 May 27;63(20):2088-2098. doi: 10.1016/j.jacc.2014.02.530. Epub 2014 Feb 27. PMID: 24583294; PMCID: PMC4029071.
Leiner, T., Bogaert, J., Friedrich, M.G. et al. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance. J Cardiovasc Magn Reson 22, 76 (2020). https://doi.org/10.1186/s12968-020-00682-4
Greenwood JP, Ripley DP, Berry C, McCann GP, Plein S, Bucciarelli-Ducci C, Dall'Armellina E, Prasad A, Bijsterveld P, Foley JR, Mangion K, Sculpher M, Walker S, Everett CC, Cairns DA, Sharples LD, Brown JM; CE-MARC 2 Investigators. Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial. JAMA. 2016 Sep 13;316(10):1051-60. doi: 10.1001/jama.2016.12680. PMID: 27570866.
Doesch C, Papavassiliu T. Diagnosis and management of ischemic cardiomyopathy: Role of cardiovascular magnetic resonance imaging. World J Cardiol. 2014 Nov 26;6(11):1166-74. doi: 10.4330/wjc.v6.i11.1166. PMID: 25429329; PMCID: PMC4244614.
Tornvall P, Gerbaud E, Behaghel A, Chopard R, Collste O, Laraudogoitia E, Leurent G, Meneveau N, Montaudon M, Perez-David E, Sörensson P, Agewall S. Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data. Atherosclerosis. 2015 Jul;241(1):87-91. doi: 10.1016/j.atherosclerosis.2015.04.816. Epub 2015 May 1. PMID: 25967935.
van Cauteren YJM, Smulders MW, Theunissen RALJ, Gerretsen SC, Adriaans BP, Bijvoet GP, Mingels AMA, van Kuijk SMJ, Schalla S, Crijns HJGM, Kim RJ, Wildberger JE, Heijman J, Bekkers SCAM. Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial. J Cardiovasc Magn Reson. 2021 Mar 22;23(1):40. doi: 10.1186/s12968-021-00723-6. PMID: 33752696; PMCID: PMC7983380.
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29. Erratum in: Circulation. 2019 Jul 30;140(5):e181-e184. PMID: 28356445.
Jone PN, Romanowicz J, Browne L, Malone LJ. Imaging Evaluation of Kawasaki Disease. Curr Cardiol Rep. 2022 Oct;24(10):1487-1494. doi: 10.1007/s11886-022-01768-4. Epub 2022 Aug 20. PMID: 35986822.
Brittain JH, Hu BS, Wright GA, Meyer CH, Macovski A, Nishimura DG. Coronary angiography with magnetization-prepared T2 contrast. Magn Reson Med. 1995 May;33(5):689-96. doi: 10.1002/mrm.1910330515. PMID: 7596274.
Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ Res. 2016 Feb 5;118(3):496-514. doi: 10.1161/CIRCRESAHA.115.306573. PMID: 26846643.
Chetrit M, Friedrich MG. The unique role of cardiovascular magnetic resonance imaging in acute myocarditis. F1000Res. 2018 Jul 30;7:F1000 Faculty Rev-1153. doi: 10.12688/f1000research.14857.1. PMID: 30109023; PMCID: PMC6069745.
Rocio Hinojar, Lucy Foote, Eduardo Arroyo Ucar, Thomas Jackson, Andrew Jabbour, Chung-Yao Yu, Jane McCrohon, David M. Higgins, Gerry Carr-White, Manuel Mayr, Eike Nagel, Valentina O. Puntmann, Native T1 in Discrimination of Acute and Convalescent Stages in Patients With Clinical Diagnosis of Myocarditis: A Proposed Diagnostic Algorithm Using CMR, JACC: Cardiovascular Imaging, Volume 8, Issue 1, 2015, Pages 37-46, ISSN 1936-878X
Nagel E, Kwong RY, Chandrashekhar YS. CMR in Nonischemic Myocardial Inflammation: Solving the Problem of Diagnosing Myocarditis or Still Diagnostic Ambiguity? JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):163-166. doi: 10.1016/j.jcmg.2019.10.023. PMID: 31918908.
Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, Kindermann I, Gutberlet M, Cooper LT, Liu P, Friedrich MG. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018 Dec 18;72(24):3158-3176. doi: 10.1016/j.jacc.2018.09.072. PMID: 30545455.
Cundari G, Galea N, De Rubeis G, Frustaci A, Cilia F, Mancuso G, Marchitelli L, Catapano F, Carbone I, Catalano C, Francone M. Use of the new Lake Louise Criteria improves CMR detection of atypical forms of acute myocarditis. Int J Cardiovasc Imaging. 2021 Apr;37(4):1395-1404. doi: 10.1007/s10554-020-02097-9. Epub 2020 Nov 15. PMID: 33190198; PMCID: PMC8026431.
Oko-Sarnowska, Zofia, Małgorzata Pyda, Olga Trojnarska, Anna Klisiewicz, Tomasz Kukulski, Mirosław Dziuk, i Edyta Płońska-Gościniak. 2015. „Kardiomiopatia przerostowa we współczesnej diagnostyce obrazowej. Stanowisko grupy ekspertów polskiego Klinicznego Forum Obrazowania Serca i Naczyń”. Kardiologia Polska 73: 39–59. doi.org/10.5306/KP.2015.0205.
Hindieh W, Weissler-Snir A, Hammer H, Adler A, Rakowski H, Chan RH. Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2017 Aug;10(8):e006309. doi: 10.1161/CIRCIMAGING.117.006309. PMID: 28794137.
Liu J, Zhao S, Yu S, Wu G, Wang D, Liu L, Song J, Zhu Y, Kang L, Wang J, Song L. Patterns of Replacement Fibrosis in Hypertrophic Cardiomyopathy. Radiology. 2022 Feb;302(2):298-306. doi: 10.1148/radiol.2021210914. Epub 2021 Nov 2. PMID: 34726536.
Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094. PMID: 25092278.
Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M. T1 Mapping: Basic Techniques and Clinical Applications. JACC Cardiovasc Imaging. 2016 Jan;9(1):67-81. doi: 10.1016/j.jcmg.2015.11.005. PMID: 26762877.
Swoboda PP, Erhayiem B, McDiarmid AK, Lancaster RE, Lyall GK, Dobson LE, Ripley DP, Musa TA, Garg P, Ferguson C, Greenwood JP, Plein S. Relationship between cardiac deformation parameters measured by cardiovascular magnetic resonance and aerobic fitness in endurance athletes. J Cardiovasc Magn Reson. 2016 Aug 17;18(1):48. doi: 10.1186/s12968-016-0266-x. PMID: 27535657; PMCID: PMC4989526.
Crean AM, Maredia N, Ballard G, Menezes R, Wharton G, Forster J, Greenwood JP, Thomson JD. 3D Echo systematically underestimates right ventricular volumes compared to cardiovascular magnetic resonance in adult congenital heart disease patients with moderate or severe RV dilatation. J Cardiovasc Magn Reson. 2011 Dec 8;13(1):78. doi: 10.1186/1532-429X-13-78. PMID: 22152255; PMCID: PMC3283510.
Becker MAJ, van der Lingen ACJ, Cornel JH, van de Ven PM, van Rossum AC, Allaart CP, Germans T. Septal Midwall Late Gadolinium Enhancement in Ischemic Cardiomyopathy and Nonischemic Dilated Cardiomyopathy-Characteristics and Prognosis. Am J Cardiol. 2023 Aug 15;201:294-301. doi: 10.1016/j.amjcard.2023.06.042. Epub 2023 Jun 30. PMID: 37393732.
aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2015 Feb;16(2):210-6. doi: 10.1093/ehjci/jeu183. Epub 2014 Sep 22. PMID: 25246502.
Gage RM, Khan AH, Syed IS, Bajpai A, Burns KV, Curtin AE, Blanchard AL, Gillberg JM, Ghosh S, Bank AJ. Twelve-Lead ECG Optimization of Cardiac Resynchronization Therapy in Patients With and Without Delayed Enhancement on Cardiac Magnetic Resonance Imaging. J Am Heart Assoc. 2018 Dec 4;7(23):e009559. doi: 10.1161/JAHA.118.009559. PMID: 30571590; PMCID: PMC6405539.
Lavall D, Vosshage NH, Geßner R, Stöbe S, Ebel S, Denecke T, Hagendorff A, Laufs U. Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy. Clin Res Cardiol. 2023 Mar;112(3):334-342. doi: 10.1007/s00392-022-02005-2. Epub 2022 Mar 31. PMID: 35355115; PMCID: PMC9998594.
Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, Gritti M, Quarta C, Knight DS, Wechalekar AD, Lachmann HJ, Perlini S, Pontone G, Moon JC, Kellman P, Gillmore JD, Hawkins PN, Fontana M. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):69-80. doi: 10.1016/j.jcmg.2019.03.026. Epub 2019 Jun 12. PMID: 31202744.
Sève P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S, Boussel L, Calender A, Androdias G, Valeyre D, El Jammal T. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis. Cells. 2021 Mar 31;10(4):766. doi: 10.3390/cells10040766. PMID: 33807303; PMCID: PMC8066110.
Smedema JP, Ainslie G, Crijns HJGM. Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis. 2020 May-Jun;63(3):271-307. doi: 10.1016/j.pcad.2020.03.011. Epub 2020 Apr 21. PMID: 32330463.
Dabir D, Luetkens J, Kuetting D, Nadal J, Schild HH, Thomas D. Myocardial Mapping in Systemic Sarcoidosis: A Comparison of Two Measurement Approaches. Rofo. 2021 Jan;193(1):68-76. English. doi: 10.1055/a-1174-0537. Epub 2020 Jun 9. PMID: 32516822.
Smedema JP, Ainslie G, Crijns HJGM. Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis. 2020 May-Jun;63(3):271-307. doi: 10.1016/j.pcad.2020.03.011. Epub 2020 Apr 21. PMID: 32330463.
Nordin S, Kozor R, Medina-Menacho K, Abdel-Gadir A, Baig S, Sado DM, Lobascio I, Murphy E, Lachmann RH, Mehta A, Edwards NC, Ramaswami U, Steeds RP, Hughes D, Moon JC. Proposed Stages of Myocardial Phenotype Development in Fabry Disease. JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1673-1683. doi: 10.1016/j.jcmg.2018.03.020. Epub 2018 May 16. PMID: 29778854.
Ponsiglione A, Gambardella M, Green R, Cantoni V, Nappi C, Ascione R, De Giorgi M, Cuocolo R, Pisani A, Petretta M, Cuocolo A, Imbriaco M. Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2022 May 23;24(1):31. doi: 10.1186/s12968-022-00859-z. PMID: 35606874; PMCID: PMC9125845.
Frustaci A, Verardo R, Grande C, Galea N, Piselli P, Carbone I, Alfarano M, Russo MA, Chimenti C. Immune-Mediated Myocarditis in Fabry Disease Cardiomyopathy. J Am Heart Assoc. 2018 Sep 4;7(17):e009052. doi: 10.1161/JAHA.118.009052. PMID: 30371172; PMCID: PMC6201436
von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology: a comprehensive summary and update. J Cardiovasc Magn Reson. 2023 Jul 24;25(1):42. doi: 10.1186/s12968-023-00950-z. PMID: 37482604; PMCID: PMC10364363.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Krzysztof Olczyk, Adriana Misiło
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 213
Number of citations: 0
